Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NexGel Inc Warrant (NXGLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -91.96% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.52 | 52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 |
52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6447417 |
Shares Outstanding - | Shares Floating 6447417 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel, Inc. is a bio-medical technology company. The Warrants allow the holder to purchase shares of common stock at a predetermined price and expiration date.
Core Business Areas
- Warrant Trading: The NexGel Inc Warrant trades on the open market allowing investors to speculate on the future performance of the underlying common stock.
Leadership and Structure
Information on leadership and organizational structure specifically for the warrant itself is generally not applicable, as it derives its value from the parent company's structure and performance. Refer to the NexGel Inc. company structure.
Top Products and Market Share
Key Offerings
- NexGel Inc Warrant: The warrant provides the right to purchase NexGel common stock at a specific price before a certain date. The value fluctuates based on the market price of the underlying common stock, time remaining until expiration, and implied volatility. Competitors do not exist as a warrant is specific to a company.
Market Dynamics
Industry Overview
The warrants market is directly tied to the overall stock market and the specific industry in which NexGel operates (biomedical). The warrants are speculative instruments tied to the underlying stock.
Positioning
The warrant's positioning is entirely dependent on the underlying stock's performance and investor sentiment towards NexGel, as well as broader market conditions.
Total Addressable Market (TAM)
The TAM is intrinsically linked to the underlying common stock's potential. No specific TAM exists for the warrant in isolation, as its value is derivative.
Upturn SWOT Analysis
Strengths
- Leveraged exposure to NexGel stock price movements
- Potential for high returns with relatively low capital outlay
- Exchange traded
Weaknesses
- Time decay (value decreases as expiration date approaches)
- High volatility
- Potential for total loss if the stock price does not exceed the strike price before expiration
Opportunities
- Significant stock price appreciation for NexGel
- Increased investor interest in the biomedical sector
- New product launches or positive clinical trial results for NexGel
Threats
- Decline in NexGel's stock price
- Negative news or events affecting NexGel
- Expiration of the warrant without reaching the strike price
- Market-wide downturn
Competitors and Market Share
Key Competitors
- Similar warrants issued by comparable biotech firms
- Other speculative biotech investments
Competitive Landscape
The warrants market is highly competitive. The value of this warrant is based on the underlying stock. Competing speculative investments exist.
Growth Trajectory and Initiatives
Historical Growth: The warrants' value is directly related to the underlying common stock.
Future Projections: Future value projections depend entirely on analysts' forecasts for NexGel's stock price.
Recent Initiatives: Not applicable to the warrant itself, but related to the parent company's initiatives.
Summary
The NexGel Inc Warrant's value is derived directly from the underlying NexGel common stock. Investing in the warrant offers leveraged exposure but carries a higher risk due to time decay and the possibility of expiring worthless if the stock price does not reach the strike price. Investors need to carefully consider their risk tolerance and outlook for NexGel when considering this investment. The warrant is a highly speculative instrument.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Financial news sources
- Market data providers
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. The value of warrants can fluctuate significantly and is subject to various risks. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.